Abstract: A novel process is disclosed for extruding an absorbable glycolide/lactide block copolymer into multifilament suture fibers. The block copolymer preferably consists of about 50/50 mole % of Glycolide/Lactide in the center segment and the overall composition of the copolymer is about 90/10 mole % Glycolide/Lactide. The novel extrusion process comprises the steps of maintaining the temperatures of at least two, preferably three or more, of the extrusion zones in the range of about 5-50° C. below the polymer melting point. The multifilament suture made with the invention process from the segmented, glycolide-rich, poly(glycolide-co-lactide) copolymers of A-B-A type, where the B-segment is an amorphous prepolymer of glycolide and lactide in the molar ratio of about 50/50 glycolide/lactide, exhibit exceptionally high breaking strength retention (BSR) at 42 days post-implantation.

Abstract: The invention relates to novel processes for the lamination of semi-crystalline, high-melting point, low glass transition polymeric films, which are extruded and subsequently laminated on various thermally sensitive substrates to form laminated medical device constructs in a specific time interval to allow low processing temperatures to avoid polymer film and/or substrate degradation or heat-related distortions. Also disclosed are laminated medical device constructs made from such processes.

Abstract: A novel process is disclosed for extruding an absorbable glycolide/lactide block copolymer into multifilament suture fibers. The block copolymer preferably consists of about 50/50 mole % of Glycolide/Lactide in the center segment and the overall composition of the copolymer is about 90/10 mole % Glycolide/Lactide. The novel extrusion process comprises the steps of maintaining the temperatures of at least two, preferably three or more, of the extrusion zones in the range of about 5-50° C. below the polymer melting point. The multifilament suture made with the invention process from the segmented, glycolide-rich, poly(glycolide-co-lactide) copolymers of A-B-A type, where the B-segment is an amorphous prepolymer of glycolide and lactide in the molar ratio of about 50/50 glycolide/lactide, exhibit exceptionally high breaking strength retention (BSR) at 42 days post-implantation.

Abstract: The invention relates to novel processes for the lamination of semi-crystalline, high-melting point, low glass transition polymeric films, which are extruded and subsequently laminated on various thermally sensitive substrates to form laminated medical device constructs in a specific time interval to allow low processing temperatures to avoid polymer film and/or substrate degradation or heat-related distortions. Also disclosed are laminated medical device constructs made from such processes.

Abstract: The invention relates to novel processes for the lamination of semi-crystalline, high-melting point, low glass transition polymeric films, which are extruded and subsequently laminated on various thermally sensitive substrates to form laminated medical device constructs in a specific time interval to allow low processing temperatures to avoid polymer film and/or substrate degradation or heat-related distortions. Also disclosed are laminated medical device constructs made from such processes.

Abstract: The invention relates to novel processes for the lamination of semi-crystalline, high-melting point, low glass transition polymeric films, which are extruded and subsequently laminated on various thermally sensitive substrates to form laminated medical device constructs in a specific time interval to allow low processing temperatures to avoid polymer film and/or substrate degradation or heat-related distortions. Also disclosed are laminated medical device constructs made from such processes.

Abstract: A barbed monofilament and a method for making the same is provided. The barbed monofilament has a substantially triangular primary cross-section defined by a periphery including first, second and third points of said triangle, and further has a plurality of barbs formed therein. Successive barbs are staggered around the periphery of the monofilament, and extend inwardly into the monofilament to a predetermined depth from the first, second and third points respectively.

Abstract: A PGA/PLA copolymer suture fiber having a fiber tenacity of between approximately 7.2 to 8.0 grams per denier and a fiber elongation between approximately 22% and 35% is produced by a process that utilizes extruder apparatus having at least one heated zone that is maintained at a temperature of from about 20° C. below the copolymer melting point to about 5° C. above the copolymer melting point, a metering pump and a heated block that are maintained at a temperature of no more than about 40° C. above the copolymer melting point, a spinneret that is maintained at a temperature of from about 40° C. to about 60° C. above the copolymer melting point, and an elongated heated sleeve extending between six and twenty inches from the spinneret that is maintained at a temperature of at least about 60° C. above the copolymer melting point.

Abstract: A prosthetic repair device comprising a nonabsorbable material, a first absorbable material having a first absorption rate and a second absorbable material having a faster absorption rate than the first absorption rate. Alternatively, the nonabsorbable material is encapsulated with a first absorbable component having a first absorption rate.

Abstract: A barbed monofilament and a method for making the same is provided. The barbed monofilament has a substantially triangular primary cross-section defined by a periphery including first, second and third points of said triangle, and further has a plurality of barbs formed therein. Successive barbs are staggered around the periphery of the monofilament, and extend inwardly into the monofilament to a predetermined depth from the first, second and third points respectively.

Abstract: A prosthetic repair device comprising a nonabsorbable material, a first absorbable material having a first absorption rate and a second absorbable material having a faster absorption rate than the first absorption rate. Alternatively, the nonabsorbable material is encapsulated with a first absorbable component having a first absorption rate.

Abstract: The present invention is directed to processes for the manufacture of multifilament yarn, including the steps of extruding multifilaments of a polymer containing at least mole 85 percent L-lactide and not more than 15 mole percent glycolide, spinning the extruded multifilaments to form a spun yarn, passing the spun multifilament yarn through an orientation roll heated at a temperature of less than 98° C. and drawing the spun multifilament yarn to a draw ratio of at least 4:1 to form an oriented multifilament fiber, annealing the oriented multifilament yarn at a temperature greater than that of the orientation roll, and redrawing the annealed, oriented multifilament yarn by at least 10 percent at a temperature lower than the temperature of annealing.

Abstract: The present invention relates to a process of forming bioabsorbable, multifilament yarn from Lactide-rich copolymers, including the steps of extruding and spinning a Lactide-rich copolymer to form a spun multifilament yarn, pre-tensioning the spun multifilament yarn to form a pre-tensioned yarn, heating the pre-tensioned yarn to form a pre-tensioned, preheated yarn, annealing and drawing the pre-tensioned, preheated yarn for a first time, annealing and drawing the yarn for a second time, cooling the twice-drawn yarn to a lower temperature, and taking-up the cooled multifilament yarn, to yarns prepared by the process and to medical devices prepared from such yarns.

Abstract: A PGA/PLA copolymer suture fiber having a fiber tenacity of between approximately 7.2 to 8.0 grams per denier and a fiber elongation between approximately 22% and 35% is produced by a process that utilizes extruder apparatus having at least one heated zone that is maintained at a temperature of from about 20° C. below the copolymer melting point to about 5° C. above the copolymer melting point, a metering pump and a heated block that are maintained at a temperature of no more than about 40° C. above the copolymer melting point, a spinneret that is maintained at a temperature of from about 40° C. to about 60° C. above the copolymer melting point, and an elongated heated sleeve extending between six and twenty inches from the spinneret that is maintained at a temperature of at least about 60° C. above the copolymer melting point.

Abstract: The present invention relates to a process of forming bioabsorbable, multifilament yarn from Lactide-rich copolymers, including the steps of extruding and spinning a Lactide-rich copolymer to form a spun multifilament yarn, pre-tensioning the spun multifilament yarn to form a pre-tensioned yarn, heating the pre-tensioned yarn to form a pre-tensioned, preheated yarn, annealing and drawing the pre-tensioned, preheated yarn for a first time, annealing and drawing the yarn for a second time, cooling the twice-drawn yarn to a lower temperature, and taking-up the cooled multifilament yarn, to yarns prepared by the process and to medical devices prepared from such yarns.

Abstract: The present invention is directed to processes for the manufacture of multifilament yarn, including the steps of extruding multifilaments of a polymer containing at least mole 85 percent L-lactide and not more than 15 mole percent glycolide, spinning the extruded multifilaments to form a spun yarn, passing the spun multifilament yarn through an orientation roll heated at a temperature of less than 98° C. and drawing the spun multifilament yarn to a draw ratio of at least 4:1 to form an oriented multifilament fiber, annealing the oriented multifilament yarn at a temperature greater than that of the orientation roll, and redrawing the annealed, oriented multifilament yarn by at least 10 percent at a temperature lower than the temperature of annealing.